# TULANE UNIVERSITY OF LOUISIANA: Targeting NKG2A/C+ CD8 T cells for anti-HIV-1 CAR-T therapy

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | TULANE UNIVERSITY OF LOUISIANA |
| Location | NEW ORLEANS, LA |
| Project | Targeting NKG2A/C+ CD8 T cells for anti-HIV-1 CAR-T therapy |
| Project number | 1R21AI203588-01 |
| Mechanism | R21 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $244,988 |
| Awarded | 2026-08-28 |
| Project period | 2026-09-01 to 2028-08-31 |
| UEI | XNY5ULPU8EN6 |

## Why this score
- Award of $244,988.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11470831). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.